机译:用恩替卡韦治疗治疗 - Na'Ve慢性乙型肝炎患者的死亡率,肝移植和肝复杂性
Department of Internal MedicineUniversity of Ulsan College of MedicineUlsan Korea;
Department of Internal MedicineUniversity of Ulsan College of MedicineUlsan Korea;
Department of Internal MedicineUniversity of Ulsan College of MedicineUlsan Korea;
Department of Internal MedicineUniversity of Ulsan College of MedicineUlsan Korea;
Department of Internal MedicineUniversity of Ulsan College of MedicineUlsan Korea;
Department of Internal MedicineUniversity of Ulsan College of MedicineUlsan Korea;
Department of Internal MedicineUniversity of Ulsan College of MedicineUlsan Korea;
Department of Internal MedicineUniversity of Ulsan College of MedicineUlsan Korea;
Department of Internal MedicineUniversity of Ulsan College of MedicineUlsan Korea;
Department of Internal MedicineUniversity of Ulsan College of MedicineUlsan Korea;
entecavir; hepatic decompensation; hepatitis B virus; hepatocellular carcinoma; tenofovir;
机译:用恩替卡韦治疗治疗 - Na'Ve慢性乙型肝炎患者的死亡率,肝移植和肝复杂性
机译:恩替卡韦vs拉米夫定治疗的慢性乙型肝炎患者的死亡率,肝移植和肝细胞癌
机译:恩替卡韦vs拉米夫定治疗的慢性乙型肝炎患者的死亡率,肝移植和肝细胞癌
机译:慢性丙型肝炎患者肝脏染色低HCV RNA水平作为干扰素治疗的预测标志物
机译:肝移植团队对并发症治疗冲突的方法和道德考虑因素
机译:恩替卡韦联合替诺福韦治疗慢性乙型肝炎对肝脂肪变性的影响
机译:肝脏脂肪变性对埃内切韦治疗慢性乙型肝炎患者结果的影响